New solutions for interventional systems: the agreement between Terumo and Medeon Biodesign

The range of Terumo solutions for interventional systems increases. Thanks to the agreement with Medeon Biodesign, Inc. (link to press release), a Taiwanese medical device company, the Gada’s historical partner will offer a new treatment option for percutaneous cardiac and peripheral catheterization procedures that use a large bore device, such as Transcatheter Aortic Valve Implementation (TAVI), Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aneurysm Repair (EVAR).

A suture-mediated closure device with two braids, the Terumo device targets percutaneous large bore procedure via the common femoral artery and it is designed to achieve rapid and reliable hemostasis at the puncture sites with excellent clinical outcomes.